These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29240460)

  • 1. Two Adolescent Cases of Psychotropic-Related Nonaffective Oniomania.
    Naguy A; Abdelhakim W; Al-Tajali A
    J Child Adolesc Psychopharmacol; 2018 May; 28(4):295-296. PubMed ID: 29240460
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole induced Impulse Control Disorders: Where do we stand?
    Mahapatra A; Sharma P; Sagar R
    Asian J Psychiatr; 2016 Oct; 23():128-130. PubMed ID: 27969070
    [No Abstract]   [Full Text] [Related]  

  • 3. Aripiprazole and impulse-control disorders in high-risk patients.
    Mohan T; Dolan S; Mohan R; Dawson J
    Asian J Psychiatr; 2017 Jun; 27():67-68. PubMed ID: 28558898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole and impulse control disorders: higher risk with the intramuscular depot formulation?
    Lertxundi U; Hernandez R; Medrano J; Domingo-Echaburu S; Garcia M; Aguirre C
    Int Clin Psychopharmacol; 2018 Jan; 33(1):56-58. PubMed ID: 28777129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole and Impulse-Control Disorders: A Recent FDA Warning and a Case Report.
    Dhillon R; Bastiampillai T; Cao CZ; Eckert TG; Tibrewal P
    Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28102975
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypersexuality induced by Aripiprazole: Two case reports and review of the literature.
    Reddy B; Ali M; Guruprasad S; Das S
    Asian J Psychiatr; 2018 Dec; 38():57-59. PubMed ID: 29107566
    [No Abstract]   [Full Text] [Related]  

  • 7. Aripiprazole: impulse control disorders. Pathological gambling.
    Prescrire Int; 2016 Nov; 25(176):271. PubMed ID: 30730124
    [No Abstract]   [Full Text] [Related]  

  • 8. Partial dopamine agonist-induced pathological gambling and impulse-control deficit on low-dose aripiprazole.
    Peterson E; Forlano R
    Australas Psychiatry; 2017 Dec; 25(6):614-616. PubMed ID: 28696131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Pathological Gambling and Impulse Control Disorders With Dopamine Agonists: A Retrospective Cohort Study.
    Sodhi M; Etminan M; Carleton B; Samii A
    J Clin Psychopharmacol; 2019; 39(6):675-676. PubMed ID: 31688453
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.
    Etminan M; Sodhi M; Samii A; Procyshyn RM; Guo M; Carleton BC
    J Clin Psychopharmacol; 2017 Feb; 37(1):102-104. PubMed ID: 27930495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole-induced behavioural disturbance related to impulse control in a clinical setting.
    Kodama M; Hamamura T
    Int J Neuropsychopharmacol; 2010 May; 13(4):549-51. PubMed ID: 19917149
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review.
    Grall-Bronnec M; Sauvaget A; Perrouin F; Leboucher J; Etcheverrigaray F; Challet-Bouju G; Gaboriau L; Derkinderen P; Jolliet P; Victorri-Vigneau C
    J Clin Psychopharmacol; 2016 Feb; 36(1):63-70. PubMed ID: 26658263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms, treatment, and medication reactions for disruptive behavior disorders.
    Finks K
    NASN Sch Nurse; 2012 May; 27(3):125-8. PubMed ID: 22712112
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathological gambling and the treatment of psychosis with aripiprazole: case reports.
    Smith N; Kitchenham N; Bowden-Jones H
    Br J Psychiatry; 2011 Aug; 199(2):158-9. PubMed ID: 21804151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys.
    Hugtenburg JG; Heerdink ER; Egberts AC
    Eur J Clin Pharmacol; 2004 Jul; 60(5):377-9. PubMed ID: 15168100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute masseter dystonia in a pediatric patient receiving aripiprazole and methylphenidate following induction of general anesthesia.
    LeRiger M; Williams J; Duncan-Wiebe G; Shukry M
    Paediatr Anaesth; 2017 Aug; 27(8):863-864. PubMed ID: 28419660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Example of an investigation of an "emergent" phenomenon in addiction vigilance: the case of methylphenidate.
    Micallef J; Frauger E; Palmaro A; Boucherie Q; Lapeyre Mestre M
    Therapie; 2015; 70(2):191-202. PubMed ID: 25858575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cabergoline-related impulse control disorder in an adolescent with a giant prolactinoma.
    Bulwer C; Conn R; Shankar A; Ferrau F; Kapur S; Ederies A; Korbonits M; Spoudeas HA
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):862-864. PubMed ID: 28346715
    [No Abstract]   [Full Text] [Related]  

  • 19. Aripiprazole Treatment of Compulsive Behaviors Associated With Methylphenidate in a Child With Down Syndrome.
    Sertdemir M; Akça ÖF
    J Clin Psychopharmacol; 2018 Apr; 38(2):159-161. PubMed ID: 29389777
    [No Abstract]   [Full Text] [Related]  

  • 20. Trichotieromania and Alopecia Areata Triggered by Aripiprazole-Methylphenidate Combo in an Autistic Child: The Nexus of Impulsivity-Compulsivity.
    Naguy A; Naguy C
    Psychopharmacol Bull; 2022 May; 52(2):157-160. PubMed ID: 35721814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.